Essential medicines list in national cancer control plans: a secondary analysis from a global study.

Essential medicines list in national cancer control plans: a secondary analysis from a global study.
复制标题

国家癌症控制计划中的基本药物清单:全球研究的二次分析。

DOI:
10.1016/s1470-2045(21)00706-3
复制
发表时间:
2022
期刊:
The Lancet. Oncology
影响因子:
--
通讯作者:
Trapani,Dario
Trapani,Dario
中科院分区:
--
文献类型:
--
作者:
Razis,Evangelia;Kassapian,Marie;Andriakopoulou,Charitini;Martei,YehodaM;Zurn,ShaliniJayasekar;Hammad,Nazik;Romero,Yannick;Dafni,Urania;Ilbawi,AndréM;Trapani,Dario

文献摘要

被引文献

相似文献

随着创新疗法的出现和癌症管理成本的上升,低收入和中等收入国家在提供有效和可持续的医疗保健方面面临越来越多的挑战。对各国如何选择和优先考虑基本癌症干预措施的理解很差,包括在制定基本药物政策方面。我们对国家癌症控制计划(NCCP)的全球数据集进行了深入的子分析,旨在确定将基本药物相关政策纳入NCCP的可能决定因素。结果表明,NCCP的全球全面性较差,并且由于癌症护理而导致的经济困难政策,特别是获得癌症药物的政策存在重大缺陷。预算拨款的具体规定、防止灾难性卫生支出的政策以及国家合作伙伴国家的国家治疗指南,有助于在基本癌症药物方面采取更加一致的政策。提供有效的癌症方案的基石在于确保全面、一致和连贯的政策制定,以指导资源选择和卫生投资,最终为所有人提供公平的健康。
With the advent of innovative therapeutics for and the rising costs of cancer management, low-income and middle-income countries face increasing challenges to deliver effective and sustainable health care. Understanding of how countries are selecting and prioritising essential cancer interventions is poor, including in the formulation of policies for essential medicines. We did an in-depth subanalysis from a global dataset of national cancer control plans (NCCPs), aiming to identify possible determinants of inclusion of policies related to essential medicines in the NCCP. The results showed poor global comprehensiveness of NCCPs, and substantial deficits in policies for financial hardships due to cancer care, specifically for access to cancer medicines. Specification of budget allocations, policy of protection from catastrophic health expenditure, and national treatment guidelines in the NCCPs contributed to more consistent policies on essential cancer medicines. The bedrock to deliver effective cancer programmes resides in the assurance of comprehensive, consistent, and coherent policy formulation, to orient resource selection and health investments, ultimately delivering equitable health for all.